IntrinsicIntrinsic
← All summaries

National Vision Holdings, Inc.

EYE
Financials & Chart →

Business Summary

National Vision Holdings, Inc. operates as one of the largest optical retailers in the United States, focusing on the value segment of the U.S. optical retail industry. The company's mission is to enhance quality of life by making eye care and eyewear more affordable and accessible, providing eye exams, eyeglasses, and contact lenses. The U.S. optical retail industry is estimated to be $69.5 billion in 2025 and is characterized by fragmentation and growth, driven by factors such as an aging population, increased managed vision care adoption, higher usage of digital screens, consistent replacement cycles for eyewear, a growing focus on health and wellness, and momentum in smart eyewear. The company competes with independent optical retailers, mass merchants, warehouse club stores, specialty retail chains, independent eye care practitioners, opticians, and online sellers of contact lenses and eyewear.

The core business model revolves around providing eye care services and selling eyewear products through a diverse portfolio of 1,250 retail stores across four brands, associated omni-channel consumer websites, and a dedicated e-commerce website, DiscountContacts.com. The company generates revenue from both product sales and services/plans, with a significant portion of revenue derived from managed vision care payors, which represented 42% of revenues from continuing operations in fiscal 2025 . The company has evolved its operating model to address changing consumer and doctor preferences, including the introduction of remote telehealth capabilities in over 800 locations to improve access to patient care.

The company's operations are primarily categorized under one reportable segment, "Owned & Host," which includes its two owned brands, America's Best Contacts and Eyeglasses ("America's Best") and Eyeglass World, as well as its Host brands, Vista Optical locations within select Fred Meyer stores and Vista Optical locations on select military bases. America's Best, with 1,057 stores , focuses on providing value and high-quality eye care, leveraging a centralized laboratory network. Eyeglass World, with 122 locations , offers a broader selection of designer brands and price points, with on-site laboratories for quick fulfillment. The Host brands, comprising 53 Vista Optical locations on military bases and 18 within Fred Meyer stores , combine product selection and service with one-stop shopping convenience, also utilizing centralized laboratories. Omni-channel and e-commerce platforms, including "buy-in-store and ship-to-home" transactions, contributed approximately 7% of net revenue in both fiscal years 2025 and 2024 .

For the fiscal year 2025, the company reported total net revenue of $1,987.5 million , an increase of 9.0% from $1,823.3 million in fiscal year 2024. Net product sales were $1,604.6 million , growing 9.7% year-over-year, while net sales of services and plans increased 6.3% to $382.9 million . Total costs applicable to revenue were $819.5 million , representing 41.2% of net revenue , a decrease of 70 basis points from 41.9% in fiscal year 2024. Selling, general and administrative (SG&A) expenses were $1,016.3 million , or 51.1% of net revenue , a decrease of 40 basis points from 51.5% in fiscal year 2024. Income from operations was $58.8 million , a significant improvement from a loss of $10.4 million in fiscal year 2024. Net income for fiscal year 2025 was $29.6 million , compared to a net loss of $28.5 million in fiscal year 2024. Diluted EPS from continuing operations was $0.37 , up from $(0.35) in fiscal year 2024. Cash and cash equivalents stood at $38.7 million as of January 3, 2026, down from $73.9 million at December 28, 2024. Total long-term debt and finance lease obligations, less current portion and debt discount, was $229.3 million as of January 3, 2026.

The company's Adjusted Comparable Store Sales Growth from continuing operations was 6.0% in fiscal year 2025, primarily driven by higher average ticket and strength in the managed care cohort, partially offset by a slight decrease in customer traffic. Net product sales increased $141.5 million , or 9.7% , primarily due to pricing and product mix initiatives in eyeglass sales of $123.4 million , or 10.8% , and contact lens sales of $16.9 million , or 5.5% . Net sales of services and plans increased $22.7 million , or 6.3% , driven by higher exam revenues of $21.1 million , or 9.0% . The company opened 33 new stores in fiscal 2025, compared to 69 in fiscal 2024, and closed 12 America's Best stores and 11 Fred Meyer stores . The 53rd week in fiscal 2025 contributed $35.6 million to net revenue and approximately $0.03 to diluted EPS .

During fiscal 2025, the company embarked on the next phase of its transformation, focusing on modernizing its business to meet contemporary consumer needs. This included refreshing the National Vision and America's Best brand identities and introducing a new America's Best brand promise, "Every Eye Deserves Better" . Operational developments included enhancing product offerings in areas like premium lens coatings and smart glasses, and implementing price increases for America's Best and Eyeglass World opening offers, evolving the product mix to include more frames over $99 . The company also launched a new customer experience platform to centrally manage customer data, communications, and analytics, replacing its previous CRM system .

Business Outlook

The company anticipates opening approximately 30 to 35 new stores in fiscal 2026 , primarily America's Best stores, with plans to reaccelerate new store openings to approximately 60 per year beginning in 2028, totaling approximately 240 new stores through 2030 . The new store model targets sales in the fifth year of operation in the range of $1.5 million to $1.7 million , with at least 55% of year five sales targeted in the first full year of operation .

The company's strategy is focused on creating a more joyful consumer experience through refreshed merchandising, updated marketing and brand assets, new in-store technologies, and an updated pricing architecture. Key growth vectors include expanding with target customer segments such as managed vision care users, progressive wearers, and Outside Rx customers. The company aims to enhance product offerings in categories like premium lens coatings, transitions, advanced materials, and more premium and luxury frames . The company believes it has a clear path to increase the percentage of revenues from managed care payors to 50% , up from 42% in fiscal 2025 .

Operationally, the company is focused on cost optimization and operating margin expansion. It expects to continue to experience wage pressure for vision care professionals and associates in 2026 . While remote medicine and EHR platforms have increased exam capacity, revenue, and profitability, they have also resulted in higher costs applicable to revenue as a percentage of revenue compared to in-store exams . The company anticipates continuing investment in remote medicine, primarily in America's Best stores, adding select locations where feasible and advantageous, depending on the state-by-state regulatory environment .

Planned capital allocation for fiscal year 2026 is expected to be approximately between $73 million and $78 million , primarily for investments in new and existing stores and IT infrastructure . The company expects to fund these capital expenditures with cash flows from operations, existing cash balances, or funds available through its revolving credit facility . The Board of Directors authorized a new share repurchase program of up to $50 million aggregate amount of common stock until December 28, 2030 , to be funded using cash on hand .

The company explicitly flags several structural headwinds and execution risks. The overall economic environment remains challenging due to macroeconomic factors such as inflation, employment rates, and global geopolitical uncertainty, which have led to reduced customer demand and shifts in consumer behaviors, particularly for cash-pay consumers . The predictability of recurring purchase behavior for the future remains uncertain . The company also faces an increasingly competitive labor market for vision care professionals, with demand exceeding supply in certain areas, leading to wage pressure and exam capacity constraints . The company's ability to implement its strategic initiatives and achieve expected returns is subject to risks such as challenges in company-wide coordination, inability to identify cost savings, and significant demands on accounting, financial, and IT systems .

Risk Factors

The company faces material risks including market volatility and an overall decline in the economy, global macroeconomic conditions, and geopolitical issues, which may affect consumer spending and behavior, thereby harming sales and profitability. The optical retail industry is highly competitive, and failure to compete successfully against larger, vertically integrated competitors, or to respond effectively to changes in retail markets and emerging technologies, could materially impact the business. Dependence on third-party managed vision care companies and a limited number of suppliers for eyeglass lenses and contact lenses exposes the company to concentration risk, with 86% of lens expenditures from one vendor and 96% of contact lens expenditures from three vendors in fiscal year 2025 . Increases in wage rates, inflation, raw material costs, and energy prices could adversely affect profitability, as the company's value-based model may limit its ability to pass on these costs. The company's growth strategy is dependent on opening new stores and increasing sales in existing stores, with risks associated with timely and cost-effective expansion, successful integration of new stores, and potential oversaturation in established markets. Failure to recruit and retain vision care professionals, or to successfully implement remote care offerings, could adversely affect business operations and financial condition, especially given increased competition for optometrists and wage pressure experienced in 2025 and expected to continue in 2026 . The company is subject to extensive and evolving federal, state, and local vision care and healthcare laws and regulations, including those related to corporate practice of medicine/optometry, managed care, privacy, data security, and consumer protection, with non-compliance potentially leading to sanctions, fines, or prosecution. Reliance on information technology systems and those of vendors for critical operations exposes the company to cybersecurity threats, data breaches, and system failures, which could result in costly investigations, litigation, and reputational damage. The company also has significant indebtedness of approximately $237.6 million as of January 3, 2026, which could limit business flexibility and increase vulnerability to adverse economic conditions, with variable interest rates on term loan borrowings of $237.6 million at a weighted average rate of 5.6% as of January 3, 2026, making it susceptible to interest rate changes.

Management Priorities

Management's message to shareholders emphasizes a strategic transformation aimed at accelerating long-term growth and strengthening profitability, initiated in fiscal 2024 and continuing into fiscal 2025. This transformation focuses on modernizing the business to meet contemporary consumer needs and wants, including creating a more joyful consumer experience with refreshed merchandising, updated marketing and brand assets, new in-store technologies, and an updated pricing architecture. The company refreshed the National Vision and America's Best brand identities in 2025 and introduced a new America's Best brand promise, "Every Eye Deserves Better" . Management is also keenly focused on cost optimization and operating margin expansion to drive a stronger core business and improved operating results. Key strategic priorities include expanding penetration within high-value customer segments such as managed care, Outside Rx customers, and progressive wearers, enhancing product offerings in premium categories, improving the customer experience through digital enhancements and clinical care, and continuing new store growth. The company plans to open approximately 30 to 35 new stores in fiscal 2026 , primarily America's Best stores, and expects to reaccelerate to approximately 60 new stores per year beginning in 2028, totaling approximately 240 new stores through 2030 . Management anticipates capital expenditures in fiscal year 2026 to be between $73 million and $78 million , primarily for investments in new and existing stores and IT infrastructure.

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 7, MD&A — Results of Operations
  2. [2] Item 7, MD&A — Results of Operations
  3. [3] Item 7, MD&A — Results of Operations
  4. [4] Item 1, Business — Our Strategy & Transformation
  5. [5] Item 1, Business — Our Strategy & Transformation
  6. [6] Item 1, Business — Our Strategy & Transformation
  7. [7] Item 1, Business — Our Strategy & Transformation
  8. [8] Item 1, Business — Our Strategy & Transformation
  9. [9] Item 1, Business — Our Strategy & Transformation
  10. [10] Item 1, Business — Our Strategy & Transformation
  11. [11] Item 1, Business — Our Strategy & Transformation
  12. [12] Item 1, Business — Our Strategy & Transformation
  13. [13] Item 1, Business — Our Strategy & Transformation
  14. [14] Item 1, Business — Our Strategy & Transformation
  15. [15] Item 1, Business — Our Strategy & Transformation
  16. [16] Item 1, Business — Our Strategy & Transformation
  17. [17] Item 1, Business — Our Strategy & Transformation
  18. [18] Item 1, Business — Our Strategy & Transformation
  19. [19] Item 1, Business — Our Strategy & Transformation
  20. [20] Item 1, Business — Our Strategy & Transformation
  21. [21] Item 1, Business — Our Strategy & Transformation
  22. [22] Item 1, Business — Our Strategy & Transformation
  23. [23] Item 1, Business — Our Strategy & Transformation
  24. [24] Item 1, Business — Our Strategy & Transformation
  25. [25] Item 1, Business — Our Strategy & Transformation
  26. [26] Item 1, Business — Our Strategy & Transformation
  27. [27] Item 1, Business — Our Strategy & Transformation
  28. [28] Item 1, Business — Our Strategy & Transformation
  29. [29] Item 1, Business — Our Strategy & Transformation
  30. [30] Item 1, Business — Our Strategy & Transformation
  31. [31] Item 1, Business — Our Strategy & Transformation
  32. [32] Item 1, Business — Our Strategy & Transformation
  33. [33] Item 1, Business — Our Strategy & Transformation
  34. [34] Item 1, Business — Our Strategy & Transformation
  35. [35] Item 1, Business — Our Strategy & Transformation
  36. [36] Item 1, Business — Our Strategy & Transformation
  37. [37] Item 1, Business — Our Strategy & Transformation
  38. [38] Item 1, Business — Our Strategy & Transformation
  39. [39] Item 1, Business — Our Strategy & Transformation
  40. [40] Item 1, Business — Our Strategy & Transformation
  41. [41] Item 1, Business — Our Strategy & Transformation
  42. [42] Item 1, Business — Our Strategy & Transformation
  43. [43] Item 1, Business — Our Strategy & Transformation
  44. [44] Item 1, Business — Our Strategy & Transformation
  45. [45] Item 1, Business — Our Industry and Competition
  46. [46] Item 1, Business — Our Customers
  47. [47] Item 1, Business — Our Strategy & Transformation
  48. [48] Item 1, Business — Our Business
  49. [49] Item 1, Business — Our Business
  50. [50] Item 1, Business — Our Host Brands
  51. [51] Item 1, Business — Our Omni-Channel and E-Commerce Platforms
  52. [52] Item 7, MD&A — Results of Operations
  53. [53] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  54. [54] Item 7, MD&A — Results of Operations
  55. [55] Item 7, MD&A — Results of Operations
  56. [56] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  57. [57] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  58. [58] Item 7, MD&A — Results of Operations
  59. [59] Item 7, MD&A — Results of Operations
  60. [60] Item 7, MD&A — Results of Operations
  61. [61] Item 7, MD&A — Results of Operations
  62. [62] Item 7, MD&A — Results of Operations
  63. [63] Item 7, MD&A — Results of Operations
  64. [64] Item 7, MD&A — Results of Operations
  65. [65] Item 7, MD&A — Results of Operations
  66. [66] Item 7, MD&A — Results of Operations
  67. [67] Item 7, MD&A — Results of Operations
  68. [68] Item 7, MD&A — Results of Operations
  69. [69] Item 7, MD&A — Results of Operations
  70. [70] Item 7, MD&A — Results of Operations
  71. [71] Item 8, Consolidated Balance Sheets
  72. [72] Item 8, Consolidated Balance Sheets
  73. [73] Item 8, Consolidated Balance Sheets
  74. [74] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  75. [75] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  76. [76] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  77. [77] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  78. [78] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  79. [79] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  80. [80] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  81. [81] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  82. [82] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  83. [83] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  84. [84] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  85. [85] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  86. [86] Item 7, MD&A — Results of Operations
  87. [87] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  88. [88] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  89. [89] Item 7, MD&A — Fiscal Year 2025 compared to Fiscal Year 2024
  90. [90] Item 1, Business — Our Strategy & Transformation
  91. [91] Item 1A, Risk Factors — Our growth is dependent on our ability to increase sales in existing stores and to successfully reinvest in existing stores.
  92. [92] Item 1, Business — Our Sales and Marketing
  93. [93] Item 1, Business — Our Business
  94. [94] Item 1, Business — Our Strategy & Transformation
  95. [95] Item 1, Business — Our Business
  96. [96] Item 1, Business — Our Business
  97. [97] Item 1, Business — Our Strategy & Transformation
  98. [98] Item 1, Business — Our Customers
  99. [99] Item 1, Business — Our Customers
  100. [100] Item 7, MD&A — Trends and Other Factors Affecting Our Business
  101. [101] Item 7, MD&A — Trends and Other Factors Affecting Our Business
  102. [102] Item 7, MD&A — Trends and Other Factors Affecting Our Business
  103. [103] Item 7, MD&A — Capital Expenditures
  104. [104] Item 7, MD&A — Capital Expenditures
  105. [105] Item 7, MD&A — Capital Expenditures
  106. [106] Item 5, Issuer Purchases of Equity Securities
  107. [107] Item 5, Issuer Purchases of Equity Securities
  108. [108] Item 7, MD&A — Trends and Other Factors Affecting Our Business
  109. [109] Item 7, MD&A — Trends and Other Factors Affecting Our Business
  110. [110] Item 7, MD&A — Trends and Other Factors Affecting Our Business
  111. [111] Item 1A, Risk Factors — We may not be successful in implementing our strategic initiatives, or in anticipating the impact of important strategic initiatives, and our plans for implementing such initiatives may be altered or delayed due to various factors, which may have a material adverse impact on our business and financial results.
  112. [112] Item 1, Business — Our Sourcing and Supplier Relationships
  113. [113] Item 1A, Risk Factors — Failure to recruit and retain vision care professionals for in-store roles or to provide remote care offerings could adversely affect our business, financial condition and results of operations.
  114. [114] Item 1A, Risk Factors — We have a significant amount of indebtedness which could adversely affect our business and financial position, including by limiting our business flexibility and preventing us from meeting our debt obligations.
  115. [115] Item 7A, Quantitative and Qualitative Disclosures About Market Risk
  116. [116] Item 7A, Quantitative and Qualitative Disclosures About Market Risk
  117. [117] Item 1, Business — Our Strategy & Transformation
  118. [118] Item 1, Business — Our Business
  119. [119] Item 1, Business — Our Strategy & Transformation
  120. [120] Item 7, MD&A — Capital Expenditures

Analysis on 5/21/2026